Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Cataract and Refractive Surgery|December 21, 2019
Clinical evaluation of a bacterially derived sodium hyaluronate 2.3% ophthalmic viscosurgical deviceDaniel H Chang, William C Christie, James C Loden, et al.Ophthalmology and Therapy|April 18, 2023
Clinical Evaluation of a Modified Light Transmission Short-Wavelength Filtering Intraocular Lens Compared to a Colorless ControlDaniel H Chang, Vance M Thompson, William C Christie, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 18, 2023
Phase 3, Randomized Study Comparing Intracameral Bimatoprost Implant 15 µg and Selective Laser Trabeculectomy in Patients with Open-Angle Glaucoma or Ocular HypertensionWilliam C Christie, Mahdi M Basha, Quoc Ho, et al.Journal of Cataract and Refractive Surgery|July 16, 2021
Visual outcomes and safety of an extended depth-of-focus intraocular lens: results of a pivotal clinical trialDaniel H Chang, Devi Priya Janakiraman, Pamela J Smith, et al.Ophthalmology. Glaucoma|June 21, 2023
Single Administration of Bimatoprost Implant: Effects on 24-Hour Intraocular Pressure and 1-Year OutcomesRobert N Weinreb, William C Christie, Felipe A Medeiros, et al.Drugs|December 30, 2019
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsE Randy Craven, Thomas Walters, William C Christie, et al.Journal of Cataract and Refractive Surgery|December 19, 2013
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 studySatish S Modi, Robert P Lehmann, Thomas R Walters, et al.American Journal of Ophthalmology|December 26, 2016
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical TrialRichard A Lewis, William C Christie, Douglas G Day, et al.Drugs|February 22, 2025
Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)Steven M Silverstein, Francesco Oddone, Miriam Kolko, et al.Pageof 1